SAB Biotherapeutics Growth Metrics (2021-2025) | SABS

Growth Metrics Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -0.01M-0.01M-0.02M-0.03M-0.12M-0.75M-0.02M-0.58M0.01M0.37M1.49M-0.25M1.67M1.90M1.48M
EBITDA Margin Growth (3y) -0.12M-0.39M1.45M-0.87M1.55M1.52M2.95M
EBITDA Margin (QoQ) -0.00M-0.00M-0.00M959.00-0.00M-0.01M-0.01M-0.09M-0.63M0.72M-0.58M0.50M-0.27M1.84M-2.32M2.42M-0.04M1.42M
EBIT Margin Growth (1y) -0.01M-0.01M-0.02M-0.03M-0.12M-0.75M-0.02M-0.58M0.01M0.37M1.49M-0.25M1.67M1.90M1.48M
EBIT Margin Growth (3y) -0.12M-0.39M1.45M-0.87M1.55M1.52M2.95M
EBIT Margin (QoQ) -0.00M-0.00M-0.00M959.00-0.00M-0.01M-0.01M-0.09M-0.63M0.72M-0.58M0.50M-0.27M1.84M-2.32M2.42M-0.04M1.42M
EBT Margin Growth (1y) 81.00-0.01M-0.02M-0.03M-0.13M-0.80M-0.02M-0.71M0.07M0.53M1.37M-0.12M1.60M1.80M1.46M
EBT Margin Growth (3y) -0.05M-0.28M1.33M-0.86M1.55M1.53M2.81M
EBT Margin (QoQ) -0.00M-0.00M-0.01M0.01M-0.01M-0.01M-0.02M-0.09M-0.68M0.76M-0.71M0.70M-0.23M1.61M-2.19M2.42M-0.03M1.27M
Enterprise Value Growth (1y) -29.78%30.77%-66.69%-94.94%-96.55%-95.78%-25.44%39.86%-299.25%-137.00%-125.59%-118.05%169.22%89.99%221.55%-1,532.44%
Enterprise Value Growth (3y) -27.00%-26.42%-27.31%-26.26%-63.78%-26.02%-38.56%-82.92%
Enterprise Value (QoQ) -75.10%28.92%214.82%-30.51%-53.63%-67.16%-52.20%-52.65%-43.18%479.82%-10.34%-167.45%89.45%-301.01%36.77%358.73%-101.53%4,970.38%-949.16%
FCF Margin Growth (1y) -0.01M-0.00M-0.02M-0.00M-0.02M-0.57M-0.02M-0.44M-0.09M0.28M0.86M-0.39M1.24M1.41M2.20M
FCF Margin Growth (3y) -0.12M-0.29M0.82M-0.83M1.13M1.12M3.04M
FCF Margin (QoQ) -0.01M0.01M-0.01M-0.00M0.00M-0.01M0.01M-0.02M-0.55M0.53M-0.40M0.33M-0.18M1.11M-1.66M1.96M-0.01M1.90M
Interest Coverage Ratio Growth (1y) -960.35%-138.00%-117.63%19.12%13.97%6.38%30.92%-170.40%-86.15%-27.41%-89.77%41.73%-3.82%-38.06%-102.08%
Interest Coverage Ratio Growth (3y) -150.82%-41.59%-41.83%-8.42%-18.47%-18.09%-38.37%
Interest Coverage Ratio (QoQ) -456.52%-31.62%-118.16%15.96%1.38%-20.36%18.92%10.60%-7.32%11.19%-217.34%38.46%26.55%-32.28%2.56%-9.65%2.33%-93.64%
Net Margin Growth (1y) 2.00-0.01M-0.02M-0.03M-0.13M-0.80M-0.02M-0.71M0.07M0.53M1.37M-0.24M0.80M1.85M1.46M
Net Margin Growth (3y) -0.05M-0.28M1.33M-0.98M0.75M1.58M2.81M
Net Margin (QoQ) -0.00M-0.00M-0.01M0.01M-0.01M-0.01M-0.02M-0.09M-0.68M0.76M-0.71M0.70M-0.23M1.61M-2.32M1.74M0.82M1.22M
Operating Margin Growth (1y) -0.01M-0.01M-0.02M-0.03M-0.12M-0.75M-0.02M-0.58M0.01M0.37M1.49M-0.25M1.67M1.90M1.48M
Operating Margin Growth (3y) -0.12M-0.39M1.45M-0.87M1.55M1.52M2.95M
Operating Margin (QoQ) -0.00M-0.00M-0.00M959.00-0.00M-0.01M-0.01M-0.09M-0.63M0.72M-0.58M0.50M-0.27M1.84M-2.32M2.42M-0.04M1.42M
Return on Assets Growth (1y) -19.00-34.00-44.00-45.00-39.006.0014.006.009.00-42.00-59.0039.00
Return on Assets Growth (3y) -49.00-70.00-89.000.00M
Return on Assets (QoQ) -6.00-7.00-10.004.00-22.00-17.00-11.0010.0024.00-9.00-18.0012.00-27.00-26.0080.00
Return on Capital Employed Growth (1y) -60.00-52.00-54.00-46.00-5.0029.0028.0014.00-21.00-74.00-101.0061.00
Return on Capital Employed Growth (3y) -86.00-97.00-127.0028.00
Return on Capital Employed (QoQ) -19.00-14.00-21.00-6.00-11.00-16.00-14.0035.0023.00-17.00-28.001.00-30.00-44.00133.00
Return on Equity Growth (1y) -14.00-54.00-83.00-89.00-56.0025.0051.0046.0012.00-90.00-163.0062.00
Return on Equity Growth (3y) -57.00-118.00-195.0018.00
Return on Equity (QoQ) 3.00-5.00-17.005.00-37.00-35.00-23.0039.0044.00-9.00-28.006.00-58.00-82.00196.00
Return on Sales Growth (1y) -50.00-182.00-410.00-596.00-0.00M-0.00M-996.00-0.00M-740.00-0.02M0.04M0.07M
Return on Sales Growth (3y) -0.00M-0.02M0.04M0.07M
Return on Sales (QoQ) -3.00-13.00-24.00-10.00-135.00-241.00-210.00-0.00M353.0082.00-0.00M552.00-0.01M0.06M0.03M